Cargando…
Cancer prevention with rapamycin
Rapamycin (sirolimus) and other rapalogs (everolimus) are anti-cancer and anti-aging drugs, which delay cancer by directly targeting pre-cancerous cells and, indirectly, by slowing down organism aging. Cancer is an age-related disease and, figuratively, by slowing down time (and aging), rapamycin ma...
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103596/ https://www.ncbi.nlm.nih.gov/pubmed/37057884 http://dx.doi.org/10.18632/oncotarget.28410 |
Ejemplares similares
-
Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
Rapamycin for longevity: opinion article
por: Blagosklonny, Mikhail V.
Publicado: (2019) -
Progeria, rapamycin and normal aging: recent breakthrough
por: Blagosklonny, Mikhail V.
Publicado: (2011) -
Rapamycin extends life- and health span because it slows aging
por: Blagosklonny, Mikhail V.
Publicado: (2013) -
DNA- and telomere-damage does not limit lifespan: evidence from rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2021)